Clinical Trial Update: Pilot Study of SBRT and CDX-1127 in Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 pilot study evaluating SBRT with CDX-1127 for prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• CDX-1127 (CDX-1127)

Snippet

Sponsor: James Larner, MD | Conditions: Prostatic Neoplasms, Prostate Cancer | Phase 1 | Status: TERMINATED